225 related articles for article (PubMed ID: 25411961)
21. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
[TBL] [Abstract][Full Text] [Related]
22. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients.
Kayacan O; Karnak D; Beder S; Güllü E; Tutkak H; Senler FC; Köksal D
Am J Clin Oncol; 2006 Aug; 29(4):328-35. PubMed ID: 16891858
[TBL] [Abstract][Full Text] [Related]
23. [Leptin serum levels in cachectic and non-cachectic lung cancer patients].
Weryńska B; Kosacka M; Gołecki M; Jankowska R
Pneumonol Alergol Pol; 2009; 77(6):500-6. PubMed ID: 20013699
[TBL] [Abstract][Full Text] [Related]
24. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.
Falconer JS; Fearon KC; Plester CE; Ross JA; Carter DC
Ann Surg; 1994 Apr; 219(4):325-31. PubMed ID: 7512810
[TBL] [Abstract][Full Text] [Related]
25. Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines.
Naing A; Dalal S; Abdelrahim M; Wheler J; Hess K; Fu S; Hong DS; Janku F; Falchook GS; Ilustre A; Ouyang F; Kurzrock R
Support Care Cancer; 2015 Sep; 23(9):2649-54. PubMed ID: 25680763
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Parameters for Cancer-Induced Sarcopenia in Patients Autopsied after Death from Colorectal Cancer.
Ohmori H; Kawahara I; Mori T; Nukaga S; Luo Y; Kishi S; Fujiwara-Tani R; Mori S; Goto K; Sasaki T; Kuniyasu H
Pathobiology; 2019; 86(5-6):306-314. PubMed ID: 31707381
[TBL] [Abstract][Full Text] [Related]
27. Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites.
Mantovani G; Macciò A; Madeddu C; Mura L; Massa E; Mudu MC; Mulas C; Lusso MR; Gramignano G; Piras MB
J Mol Med (Berl); 2001 Jul; 79(7):406-14. PubMed ID: 11466563
[TBL] [Abstract][Full Text] [Related]
28. The correlation between a chronic inflammatory marker Tartrate-resistant acid phosphatase 5a with cancer cachexia.
Wu YY; Chao TY; Liu HY; Huang TC; Chen JH; Dai MS; Janckila A; Lai SW; Chang PY
J BUON; 2015; 20(1):325-31. PubMed ID: 25778334
[TBL] [Abstract][Full Text] [Related]
29. Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?
Scheede-Bergdahl C; Watt HL; Trutschnigg B; Kilgour RD; Haggarty A; Lucar E; Vigano A
Clin Nutr; 2012 Feb; 31(1):85-8. PubMed ID: 21855185
[TBL] [Abstract][Full Text] [Related]
30. Role of NF-kappaB and cytokine in experimental cancer cachexia.
Zhou W; Jiang ZW; Tian J; Jiang J; Li N; Li JS
World J Gastroenterol; 2003 Jul; 9(7):1567-70. PubMed ID: 12854165
[TBL] [Abstract][Full Text] [Related]
31. [Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.].
Deveci Y; Deveci F; Ilhan N; Karaca I; Turgut T; Muz MH
Tuberk Toraks; 2010; 58(2):162-72. PubMed ID: 20865569
[TBL] [Abstract][Full Text] [Related]
32. [The incidence and pathogenesis of cancer anorexia-cachexia syndrome in lung cancer].
Kosacka M; Weryńska B; Gołecki M; Jankowska R; Passowicz-Muszyńska E
Pneumonol Alergol Pol; 2008; 76(5):360-5. PubMed ID: 19003767
[TBL] [Abstract][Full Text] [Related]
33. Steep elevation of blood interleukin-6 (IL-6) associated only with late stages of cachexia in cancer patients.
Iwase S; Murakami T; Saito Y; Nakagawa K
Eur Cytokine Netw; 2004; 15(4):312-6. PubMed ID: 15627639
[TBL] [Abstract][Full Text] [Related]
34. Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice.
Choi YK; Jung KY; Woo SM; Yun YJ; Jun CY; Park JH; Shin YC; Cho SG; Ko SG
Mediators Inflamm; 2014; 2014():736563. PubMed ID: 24963216
[TBL] [Abstract][Full Text] [Related]
35. L-carnitine ameliorates cancer cachexia in mice by regulating the expression and activity of carnitine palmityl transferase.
Liu S; Wu HJ; Zhang ZQ; Chen Q; Liu B; Wu JP; Zhu L
Cancer Biol Ther; 2011 Jul; 12(2):125-30. PubMed ID: 21532335
[TBL] [Abstract][Full Text] [Related]
36. Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system.
Filippatos GS; Tsilias K; Venetsanou K; Karambinos E; Manolatos D; Kranidis A; Antonellis J; Kardaras F; Anthopoulos L; Baltopoulos G
Int J Cardiol; 2000; 76(2-3):117-22. PubMed ID: 11104865
[TBL] [Abstract][Full Text] [Related]
37. NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients.
Boguszewicz Ł; Bieleń A; Mrochem-Kwarciak J; Skorupa A; Ciszek M; Heyda A; Wygoda A; Kotylak A; Składowski K; Sokół M
Metabolomics; 2019 Aug; 15(8):110. PubMed ID: 31420744
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor not detectable in patients with clinical cancer cachexia.
Socher SH; Martinez D; Craig JB; Kuhn JG; Oliff A
J Natl Cancer Inst; 1988 Jun; 80(8):595-8. PubMed ID: 3373550
[TBL] [Abstract][Full Text] [Related]
39. Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia.
Yang QJ; Zhao JR; Hao J; Li B; Huo Y; Han YL; Wan LL; Li J; Huang J; Lu J; Yang GJ; Guo C
J Cachexia Sarcopenia Muscle; 2018 Feb; 9(1):71-85. PubMed ID: 29152916
[TBL] [Abstract][Full Text] [Related]
40. Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities.
Permuth JB; Clark Daly A; Jeong D; Choi JW; Cameron ME; Chen DT; Teer JK; Barnett TE; Li J; Powers BD; Kumar NB; George TJ; Ali KN; Huynh T; Vyas S; Gwede CK; Simmons VN; Hodul PJ; Carballido EM; Judge AR; Fleming JB; Merchant N; Trevino JG
Cancer Med; 2019 Jun; 8(6):3314-3324. PubMed ID: 31074202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
